Whether P2Y12 antagonists reduce the migration of P2Y12+ macrophages to the site of tumor in vivo and whether P2Y12+ macrophages promote tumor growth and progression needs to be determined using appropriate mouse models. The gene discussed is P2RY12; the disease is neoplasm.